Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.
BACKGROUND & AIMS The rising prevalence of cirrhosis, driven by non-viral etiologies, strains healthcare systems and necessitates personalized hepatocellular carcinoma (HCC) surveillance. We conducted a head-to-head comparison of the Toronto HCC risk index (THRI) and aMAP score within an etiology-diverse Western popula...